Saturday, November 23, 2024
HomeTagsOregon Health

Oregon Health

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial

SQZ Biotechnologies Company, focused on unlocking the full potential of cell therapies, announced that, according to RECIST 1.1 criteria, a confirmed complete response was...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics